×
Back to Agenda
Session 5
Session Chair(s)
Seiki Yamazaki
Director, Clinical Informatics & Innovation, Pfizer Japan Inc., Japan
Speaker(s)
Tatsuhiko Sugimoto
Reviewer, Office of Safety II, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Have an account?